Quantitation of the novel anticonvulsant remacemide in rat and dog plasma and urine: application of the plasma methodology to measure the plasma protein binding of remacemide.
Sensitive and selective methods have been developed for quantitation of the novel anticonvulsant remacemide in rat and dog plasma and urine. The methods employed liquid-liquid extraction (urine) or ion-exchange solid-phase extraction (plasma), with an internal standard, followed by high-performance liquid chromatography with ultraviolet detection. The detection limit for both methods was 10 ng/ml. Overall accuracy was 0.00% for plasma and -1.4% for urine with a precision of 6.04 and 3.87% for plasma and urine, respectively. The standard curves were linear for both plasma and urine over a wide concentration range (9.96-2490 ng/ml). The plasma method was also applied to measurement of in vitro plasma protein binding of remacemide in rat, dog and human plasma.
Wilson
T C
TC
Department of Preclinical Research Support, Fisons Pharmaceutical Division, Rochester, NY 14623.
Eisman
M S
MS
Machulskis
G E
GE
D000081:Acetamides / Q000097:blood* / Q000652:urine*; D000818:Animals; D000927:Anticonvulsants / Q000097:blood* / Q000652:urine*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D004285:Dogs; D006801:Humans; D011485:Protein Binding; D051381:Rats; D017207:Rats, Sprague-Dawley
D000081:Acetamides; D000927:Anticonvulsants; C067553:remacemide